Klox Technologies Inc a Canada-based regenerative medicine company focused on the development and commercialisation of its proprietary fluorescent light energy biomodulation System (FB System) in dermatology, wound care, and animal health, announced yesterday that it has named Domenic Serafino and Dr Richard Markoff as its new directors.
Serafino is a medical device veteran, with more than 25 years of experience. Presently, he serves as chairman and CEO of Venus Concept with direct operations in 27 of these markets and over 500 employees. He brings extensive experience in sales, marketing and global operations.
Dr Markoff has more than 25 years' experience as a supply chain executive. He is co-founder and partner at Innovobot and earlier managed Global Supply Chain Standards at L'Oreal cosmetics. He holds a PhD in Supply Chain Management and is a lecturer and researcher at Ecole polytechnique federale de Lausanne and the International Institute for Management Development in Switzerland.
TELA Bio launches LIQUIFIX for US hernia surgery
Cognizant and NVIDIA partner to revolutionize drug discovery with generative AI
Neupulse raises funds for Tourettes Syndrome wearable tech
Bonesupport gains FDA clearance for CERAMENT G in open fractures
Epitomee submits Weight Loss Capsule for FDA approval in US
Halma acquires Rovers Medical Devices
boston Scientific granted FDA approval for AGENT Drug-Coated Balloon